Cell-based Assay Market

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 28)
    4.1 Cell-Based Assays: Market Overview
    4.2 Cell-Based Assays Market, By Product & Service and Application (2018)
    4.3 Geographical Snapshot of the Cell-Based Assays Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Preference for Cell-Based Assays
                    5.2.1.2 Growing Research Funding
                    5.2.1.3 Growth in the Number of Drug Discovery Activities
           5.2.2 Restraint
                    5.2.2.1 High Cost of Instruments and Restrictions on Reagent Use
           5.2.3 Opportunities
                    5.2.3.1 High-Growth Asian Countries
                    5.2.3.2 Application of Novel Cell-Based Assays in Cancer Research

6 Cell-Based Assays Market, By Product & Service (Page No. - 35)
    6.1 Introduction
    6.2 Consumables
           6.2.1 Reagents
                    6.2.1.1 Reagents Have Widespread Usage in Life Sciences Due to Their Application in Immunology Research, Disease Research, and Cancer Diagnostics
           6.2.2 Assay Kits
                    6.2.2.1 Reporter Gene Assays
                               6.2.2.1.1 Reporter Gene Assays Can Be Used With Limited Resources for the Establishment of Hts Platforms, Presenting Opportunities for Small Laboratories With Limited Resources
                    6.2.2.2 Second Messenger Assays
                               6.2.2.2.1 Second Messenger Assays Allow the Detection and Characterization of All Compound Classes—A Key Driver for Market Growth
                    6.2.2.3 Cell Growth Assays
                               6.2.2.3.1 Cell Viability and Cell Proliferation Assays are the Two Most Important in Vitro Quantification Techniques for Assessing Cell Growth
                    6.2.2.4 Cell Death Assays
                               6.2.2.4.1 Cell Death Quantification is Essential in Drug Development to Identify the Manner in Which Potential Drugs Could Inhibit Or Enhance Molecular Targets—A Key Factor Propelling Market Demand
                    6.2.2.5 Other Assay Kits
           6.2.3 Probes & Labels
                    6.2.3.1 Effective Labeling of Cells Helps in Studying Cellular Events in A Spatial and Temporal Context—A Key Factor Driving the Demand for Probes and Labels
           6.2.4 Microplates
                    6.2.4.1 Increasing Demand for Cell-Based Assays in Drug Discovery, Basic Research, and Preclinical Safety Studies is Encouraging the Consumption of Microplates
           6.2.5 Cell Lines
                    6.2.5.1 Immortalized Cell Lines
                               6.2.5.1.1 Advantages of Immortalized Cell Lines Creating A Demand for These Cell Lines Over Primary and Stem Cell Lines
                    6.2.5.2 Primary Cell Lines
                               6.2.5.2.1 Primary Cell Lines are More Sensitive as Compared to Immortalized Cell Lines—A Key Factor Limiting Market Growth
                    6.2.5.3 Stem Cell Lines
                               6.2.5.3.1 Stem Cell Lines are Alternative Methodologies to Address the Cellularity Issues That Involve the Directed Differentiation of Embryonic Stem (Es) Cells Or Induced Pluripotent Stem Cells (Ips)
           6.2.6 Other Consumables
    6.3 Instruments
           6.3.1 Biotechnology Companies Aim to Streamline Their Workflows to Improve Productivity and Reduce Costs, Which Will Drive the Growth of the Instruments Market
    6.4 Services

7 Cell-Based Assays Market, By Application (Page No. - 53)
    7.1 Introduction
    7.2 Drug Discovery
           7.2.1 Toxicity Studies
                    7.2.1.1 Increasing Adoption of High-Content Screening for Evaluating Cytotoxicity is A Factor Stimulating the Use of Cell-Based Assays for Toxicity Studies
           7.2.2 Pharmacokinetic Studies
                    7.2.2.1 Demand for Adme Studies to Rise Due to the Growing Need for Improved Clinical Success—A Major Factor Driving Growth
           7.2.3 Pharmacodynamic Studies
                    7.2.3.1 Increasing Number of Pharmacodynamics Studies Globally to Drive Growth in the Cell-Based Assays Market
    7.3 Basic Research
           7.3.1 Increasing Funding By Government Institutes for Basic Research to Drive the Demand for Cell-Based Assay Products & Services
    7.4 Other Applications

8 Cell-Based Assays Market, By End User (Page No. - 61)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies
           8.2.1 The Demand for Cell-Based Assays in This End-User Segment is Primarily Driven By the Growth in the Number of R&D Activities
    8.3 Academic & Government Institutes
           8.3.1 Increasing Interest of Academic Institutions to Develop Assays for Innovative Applications to Drive the Demand for Cell-Based Assays in This End-User Segment
    8.4 Contract Research Organizations
           8.4.1 Growth in Outsourcing to Drive the Demand for Cell-Based Assays in Contract Research Organizations

9 Cell-Based Assays Market, By Region (Page No. - 66)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 UK
           9.3.2 Germany
           9.3.3 France
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 93)
     10.1 Overview
     10.2 Market Ranking Analysis, 2017
             10.2.1 Cell-Based Assays Market Ranking, By Key Player, 2017
     10.3 Key Strategies
             10.3.1 Product Launches, 2015–2018
             10.3.2 Expansions, 2015–2018
             10.3.3 Collaborations, 2015–2018:
             10.3.4 Acquisitions, 2015–2018
     10.4 Competitive Leadership Mapping (2017)
     10.5 Visionary Leaders
     10.6 Innovators
             10.6.1 Dynamic Differentiators
             10.6.2 Emerging Companies
     10.7 Competitive Leadership Mapping for Start-Ups (2017)
             10.7.1 Progressive Companies
             10.7.2 Starting Blocks
             10.7.3 Responsive Companies
             10.7.4 Dynamic Companies

11 Company Profiles (Page No. - 101)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Thermo Fisher Scientific Inc.
     11.2 Danaher Corporation
     11.3 Becton, Dickinson and Company
     11.4 Ge Healthcare
     11.5 Merck KGaA
     11.6 Lonza Group Ltd.
     11.7 Perkinelmer, Inc.
     11.8 Charles River Laboratories, Inc.
     11.9 Cell Signaling Technology, Inc.
     11.10 Promega Corporation
     11.11 Cisbio
     11.12 Cell Biolabs, Inc.

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 126)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details

List of Tables (79 Tables)

Table 1 Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Cell-Based Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Cell-Based Consumables Market, By Type, 2017–2024 (USD Million)
Table 4 Cell-Based Reagents Market, By Region, 2017–2024 (USD Million)
Table 5 Cell-Based Assay Kits Market, By Type, 2017–2024 (USD Million)
Table 6 Cell-Based Assay Kits Market, By Region, 2017–2024 (USD Million)
Table 7 Reporter Gene Assays Market, By Region, 2017–2024 (USD Million)
Table 8 Second Messenger Assays Market, By Region, 2017–2024 (USD Million)
Table 9 Cell Growth Assays Market, By Region, 2017–2024 (USD Million)
Table 10 Cell Death Assays Market, By Region, 2017–2024 (USD Million)
Table 11 Other Assay Kits Market, By Region, 2017–2024 (USD Million)
Table 12 Cell-Based Probes & Labels Market, By Region, 2017–2024 (USD Million)
Table 13 Cell-Based Microplates Market, By Region, 2017–2024 (USD Million)
Table 14 Cell Lines Market, By Type, 2017–2024 (USD Million)
Table 15 Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 16 Immortalized Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 17 Primary Cell Lines Market For, By Region, 2017–2024 (USD Million)
Table 18 Stem Cell Lines Market, By Region, 2017–2024 (USD Million)
Table 19 Other Consumables Market, By Region, 2017–2024 (USD Million)
Table 20 Cell-Based Instruments Market, By Region, 2017–2024 (USD Million)
Table 21 Cell-Based Assay Services Market, By Region, 2017–2024 (USD Million)
Table 22 Market, By Application, 2017–2024 (USD Million)
Table 23 Market for Drug Discovery, By Region, 2017–2024 (USD Million)
Table 24 Market for Drug Discovery, By Type, 2017–2024 (USD Million)
Table 25 Market for Toxicity Studies, By Region, 2017–2024 (USD Million)
Table 26 Market for Pharmacokinetic Studies, By Region, 2017–2024 (USD Million)
Table 27 Market for Pharmacodynamic Studies, By Region, 2017–2024 (USD Million)
Table 28 Market for Basic Research, By Region, 2017–2024 (USD Million)
Table 29 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 30 Market, By End User, 2017–2024 (USD Million)
Table 31 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 32 Market for Academic & Government Institutes, By Region, 2017–2024 (USD Million)
Table 33 Market for Contract Research Organizations, By Region, 2017–2024 (USD Million)
Table 34 Market, By Region, 2017–2024 (USD Million)
Table 35 North America: Market, By Country, 2017–2024 (USD Million)
Table 36 North America: Market, By Products & Services, 2017–2024 (USD Million)
Table 37 North America: Market, By Application, 2017–2024 (USD Million)
Table 38 North America: Market, By End User, 2017–2024 (USD Million)
Table 39 US: Market, By Products & Services, 2017–2024 (USD Million)
Table 40 US: Market, By Application, 2017–2024 (USD Million)
Table 41 US: Market, By End User, 2017–2024 (USD Million)
Table 42 Canada: Market, By Products & Services, 2017–2024 (USD Million)
Table 43 Canada: Market, By Application, 2017–2024 (USD Million)
Table 44 Canada: Market, By End User, 2017–2024 (USD Million)
Table 45 Europe: Market, By Country, 2017–2024 (USD Million)
Table 46 Europe: Market, By Products & Serivecs, 2017–2024 (USD Million)
Table 47 Europe: Market, By Application, 2017–2024 (USD Million)
Table 48 Europe: Market, By End User, 2017–2024 (USD Million)
Table 49 UK: Market, By Products & Services, 2017–2024 (USD Million)
Table 50 UK: Market, By Application, 2017–2024 (USD Million)
Table 51 UK: Market, By End User, 2017–2024 (USD Million)
Table 52 Germany: Market, By Products & Services, 2017–2024 (USD Million)
Table 53 Germany: Market, By Application, 2017–2024 (USD Million)
Table 54 Germany: Market, By End User, 2017–2024 (USD Million)
Table 55 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 56 France: Market, By Application, 2017–2024 (USD Million)
Table 57 France: Market, By End User, 2017–2024 (USD Million)
Table 58 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 59 RoE: Market, By Application, 2017–2024 (USD Million)
Table 60 RoE: Market, By End User, 2017–2024 (USD Million)
Table 61 APAC: Market, By Country, 2017–2024 (USD Million)
Table 62 APAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 63 APAC: Market, By Application, 2017–2024 (USD Million)
Table 64 APAC: Market, By End User, 2017–2024 (USD Million)
Table 65 China: Market, By Product & Service, 2017–2024 (USD Million)
Table 66 China: Market, By Application, 2017–2024 (USD Million)
Table 67 China: Market, By End User, 2017–2024 (USD Million)
Table 68 Japan: Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Japan: Market, By Application, 2017–2024 (USD Million)
Table 70 Japan: Market, By End User, 2017–2024 (USD Million)
Table 71 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 72 India: Market, By Application, 2017–2024 (USD Million)
Table 73 India: Market, By End User, 2017–2024 (USD Million)
Table 74 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 75 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 76 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 77 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 78 RoW: Market, By Application, 2017–2024 (USD Million)
Table 79 RoW: Market, By End User, 2017–2024 (USD Million)

List of Figures (30 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product & Service, 2019 vs 2024 (USD Million)
Figure 7 Market, By Application, 2019 vs 2024 (USD Million)
Figure 8 Market, By End User, 2019 vs 2024 (USD Million)
Figure 9 Market, By Region, 2019 vs 2024 (USD Million)
Figure 10 Growth in the Number of Drug Discovery Activities is Driving the Demand for Cell-Based Assays
Figure 11 Drug Discovery Applications Accounted for the Largest Share of the Cell-Based Assays: Market in 2018
Figure 12 Countries in APAC to Register A Higher Growth Rate During the Forecast Period
Figure 13 Cell-Based Assays: Market: Drivers, Restraints, and Opportunities
Figure 14 Consumables to Dominate the Cell-Based Assays: Market During the Forecast Period
Figure 15 Drug Discovery Applications to Witness the Highest Growth During the Forecast Period
Figure 16 Pharmaceutical & Biotechnology Companies Estimated to Be the Largest End Users of Cell-Based Assays During the Forecast Period
Figure 17 North America to Dominate the Cell-Based Assays: Market
Figure 18 North America: Cell-Based Assay Market Snapshot
Figure 19 APAC: Cell-Based Assays: Market Snapshot
Figure 20 Key Developments in the Cell-Based Assays: Market From 2015 to 2019
Figure 21 MnM Dive-Vendor Comparison Matrix: Cell-Based Assays: Market
Figure 22 MnM Dive-Vendor Comparison Matrix for Start-Ups: Cell-Based Assays: Market
Figure 23 Thermo Fisher Scientific Inc.: Company Snapshot (2017)
Figure 24 Danaher Corporation: Company Snapshot (2018)
Figure 25 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 26 GE Healthcare: Company Snapshot (2018)
Figure 27 Merck KGaA: Company Snapshot (2017)
Figure 28 Lonza Group Ltd.: Company Snapshot (2017)
Figure 29 Perkinelmer, Inc.: Company Snapshot (2018)
Figure 30 Charles River Laboratories, Inc.: Company Snapshot (2017)

The study involved four major activities to estimate the current size of the cell-based assays market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as assay kits manufacturers, vendors, distributors, and scientists from academic and government institutes and biopharma companies were consulted for this report. The demand side of this market is characterized by significant use of cell-based assays consumables due to the increasing number of drug discovery activities. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell-based assays market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and markets have been identified through extensive secondary research
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size-using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell-based assays industry.

Report Objectives

• To define, describe, and forecast the cell-based assays market by product, application, end user, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product launches, and research and development activities in the cell-based assays market

Scope of the Report

This research report categorizes the cell-based assays market into the following segments and subsegments:

Cell-based Assays Market, by Product & Service

• Consumables
  • Reagents
  • Assay Kits
    • Reporter Gene Assays
    • Second Messenger Assays
    • Cell Growth Assays
  • Cell Lines
    • Immortalized Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
  • Microplates
  • Probes & Labels
• Instruments
• Services

Cell-based Assays Market, by Application

• Drug Discovery
  • Pharmacodynamic Studies
  • Pharmacokinetic Studies
  • Toxicity Studies
• Basic Research

Cell-based Assays Market, by End User

• Pharmaceutical and Biotechnology Companies
• Academic & Government Institutions
• Contract Research Organizations

Cell-based Assays Market, by Region

• North America
• Europe
• Asia Pacific
• Rest of the World

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis:

• Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis:

• Further breakdown of the European, Asia Pacific, and the Rest of World regional segments into their respective countries for this market

Company Information:

• Detailed analysis and profiling of additional market players (up to 5)

Volume Data:

• Customization options for volume data (number of units sold) and customization options for volume data (number of tests)

Opportunities Assessment:

• A detailed report underlining the various growth opportunities presented in the market